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Abstract:  Background and Objectives: Urinary tract infections (UTI) caused by enterohemorrhagic Escherichia coli 
(EHEC) is one of the most important diseases in infants and children. If there would not be any useful diagnosis and  
treatment it may be resulted in diseases such as acute renal failure, thrombocytopenia and hemolytic anemia. The aim of 
this study was to determine frequency of verotoxigenic E.coli isolates in urine of children with (UTIs) in Mofid children 
Hospital.  
Methods: During one year from September 2008 to august 2009, urine specimens were taken from children who suspected 
to UTI admitted to Mofid Children Hospital. E.coli strains that indicated beta hemolytic on sheep blood agar, negative 
sorbitol fermentation on SMAC (sorbitol macconky agar) and negative motility on SIM were tested by PCR and serologic 
(VITEC-RPLA kit) methods for detecting toxin genes and production of toxin, respectively.  
Results: Among 12572 urine specimens were taken from children admitted to Mofid hospital, we isolated 378 E.coli from 
urine samples which only 9 isolates were EHEC. Only five EHEC strains (55%) which produced vtx genes, were detected 
by serologic and PCR methods.  
Conclusion: The prevalence of urinary infections caused by EHEC strains is very significant because it causes aggravating 
pathologic effects. Thus we suggest rapid method for identification of this bacteria and proper treatment to Inhibition of 
unwanted complications. 
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INTRODUCTION 
 Escherichia  coli is the predominant facultative anaer-
obe of the human colonic flora. The organism typically 
colonizes the infant gastrointestinal tract within hours of 
life, and, thereafter, E. coli and the host derive mutual 
benefit [1].Verotoxigenic Escherichia coli (VTEC) are 
named for their ability to produce toxins with a cytopathic 
effect on Vero cells. They are also referred to as shiga 
toxin-producing  E coli (STEC) because their cytotoxins 
closely resemble the shiga toxin produced by Shigella dys-
enteriae 1. Two types of shiga toxin are produced: shiga 
toxin 1 (Stx1), which is most closely related to that pro-
duced by S. dysenteriae, and shiga toxin 2 (Stx2), which 
has several variants. Entero-hemorrhagic E coli (EHEC) 
are the subgroup of VTEC organisms with demonstrated 
human pathogenicity. While most VTEC belong to E coli 
serogroup O157, verotoxin production has been identified  
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in more than 200 serogroup [2]. Hemolytic uremic syndrome 
is the most common cause of acute renal failure in children, 
and the incidence of this syndrome in children is increasing 
worldwide [3]. E. coli O157:H7 is believed to cause more than 
80 percent of the STEC infections that lead to hemolytic ure-
mic syndrome [4]. Hemolytic uremic syndrome primarily oc-
curs in children one to 10 years of age [5,6] with an average 
annual incidence of one to three cases per 100,000 children [7]
 
and a survival rate of nearly 95 percent. Some studies indicate 
that rural populations are more at risk than urban populations 
[8,9] and the incidence is higher in warmer months of year, 
peaking from June to September
 [10].  
  Occurrences may be sporadic or present as an outbreak. A 
study conducted in the United Kingdom, in which confections 
intentionally were artificially contaminated with E. coli 
O157:H7 showed that the Shiga toxin-producing strains could 
survive for as long as one year, depending on storage condi-
tions [11]. Three to 15 percent of persons who have STEC 
with diarrhea can develop hemolytic uremic syndrome [12]. 
Young children and older persons with altered immune re-
sponse, [13] as well as persons who have been in contact with 
infected farm animals, are particularly vulnerable. In addition 
to age, risk factors associated with hemolytic uremic syndrome 2    The Open Microbiology Journal, 2012, Volume 6  Navidinia et al. 
included bloody diarrhea fever, and elevated white blood 
cell count and C-reactive protein levels [14]. The use of 
antibiotics or antimotility/antidiarrheal and antimicrobial 
agents in early stages of diarrhea has been shown to in-
crease the risk of hemolytic uremic syndrome because the 
gut is exposed to a greater number of toxins for a longer 
period as intestinal motility slows [10, 15]. The pathogen is 
relatively tolerant to acid and can survive in fermented 
foods and fresh vegetable produce. 
  Waterborne transmission has also been reported, both 
from contaminated drinking-water and from recreational 
waters. Person-to-person contact is an important mode of 
transmission, particularly in institutional settings, such as 
day care centers, nursing homes and hospitals [16]. Reports 
of EHEC as a cause of diarrhea in other African countries 
are sporadic. In a study of childhood diarrhea in Nigeria, 
samples of EHEC were isolated from 5.1% of children 
with diarrhea [17]. A study from Japan in 1996 by Japan 
reported 9451 cases of EHEC infections, 1808 of which 
were hospitalized and 12 died; three-quarters of all these 
cases occurred during six major outbreaks. In the largest 
outbreak, in SakaiCity, 5727 people (0.5% of the city's 
population) were affected, and white radish sprouts served 
at school lunch were the most likely food vehicle. In out-
breaks reported in other areas E. coli 0157 was also iso-
lated from the salad and seafood sauce that were served at 
school lunches. In 1997, E. coli 0157 was detected in wild 
venison and white radish sprouts associated with sporadic 
infections [16]. In other parts of Asia, EHEC infections 
have been reported. In Malaysia, E. coli 0157:H7 has been 
isolated from the stools of patients with diarrheal illness 
[18]. In a study at a Bangkok hospital in Thailand, EHEC 
was identified in 7% of children with bloody diarrhea in 
whom other enteric pathogens were not identified [19]. In 
the Republic of Korea, EHEC was isolated from 1.3% of 
children with no bloody diarrhea. An investigation into the 
etiology of childhood diarrhea in China, EHEC isolated 
from 6.8% of children with diarrhea [20]. This article will 
review the diarrheagenic E. coli strains, which include sev-
eral emerging pathogens of worldwide public health im-
portance, and will specifically focus on pathogens afflict-
ing humans. We will particularly concentrate on the E. coli 
strain whose study has advanced most over the last decade, 
E. coli (EHEC). The indications for culturing for EHEC 
differ from those for the rest of the diarrheagenic E. coli 
categories. Routine screening test for E. coli in urine are 
most often recovered on blood agar and eosin methylene-
blue agar, which selectively grow members of the Entero-
bacteriaceae , biochemical test such as TSI,SIM, citrate, 
Urease were used, and also serologic test with VTEC-
RPLA latex agglutination kit production of toxin and mul-
tiplex PCR methods used for identifying vtxB1- and vtxA2 
Phenotypes. 
MATERIAL AND METHODS 
Clinical Specimens 
  Overall criteria for diagnosis UTI was growth of 10
4 
CFU/mL of a urinary tract pathogen) in patients who did 
not have another potential
 source for their fever, a history
 
of UTI, malodorous urine or hematuria, appeared "ill",
 ab-
dominal or suprapubic tenderness on examination, or fever 
39°C [25]. Patients who had received antibiotic treatment 
within the preceding 2 weeks, and those with known congenital 
anomalies of urinary tract or central nervous system-associated 
anomalies were excluded. 
  In this "prospective study" we collected 12572 urine sam-
ples from Children with UTI in Mofid children hospital Te-
hran, Iran /The age of patients ranged between 1-12 years old. 
Samples were collected in sterile plastic containers. The sam-
ples were inoculated in the Blood agar and EMB. After 24 
hours of incubation at 37°C significant isolated microorgan-
isms were identified by using Gram stain, catalase, oxidase, 
and other conventional tests. Each colonies which have -
hemolysis and Sorbitol fermentation negative on SMAC agar, 
suspected to EHEC so used Reverse passive Latex Agglutina-
tion Method for Detecting and Characterizing Verotoxins 
(Shiga Toxins) in Escherichia coli. 
VTEC-RPLA-SEIKEN 
  A reverse passive latex agglutination was performed ac-
cording to the Manufacturer’s instructions (No: 230553). 
Collection of Samples and Preparation of Template DNA 
for PCR 
  A total of 378 E.coli were collected over the periods from 1 
October 2008 to 31 June 2009. All bacteria plated directly on 
both blood agar and SMAC agar (Oxoid, Wesel, Germany) 
and incubated overnight at 37°C. All colonies suspended to 
  VTEC were diluted in 1 ml of Nutrient broth with 
15%glycerol. The suspension was diluted 1:20 in PCR-grade 
H2O (Appli- Chem, Darmstadt, Germany); 1/10 was taken 
from this mixture for PCR with either a conventional instru-
ment [21]. 
Extraction of DNA and Detection of STEC Strains by   
(M-PCR) 
  One mL of bacterial material was suspended in sterile wa-
ter and heated at 100 °C during 10 min to release DNA. PCR 
was directly performed using consensus primers amplifying 
the toxin vtx genes Table 1. For each PCR-positive sample, a 
maximum of 20 colonies obtained on the MacConkey agar 
plate was tested separately in order to isolate VTEC strains. 
 Positive  vtx consensus PCR isolated colonies were subse-
quently identified through biochemical tests (indole produc-
tion, Klieger test, ß-glucuronidase activity).The vtx1 and vtx2 
genes were finally detected in sample isolates by the Multi-
plex-PCR procedure. Each of the primers was used at 20 pM, 
with 200 mM each deoxynucleoside triphosphates (Boehringer 
Mannheim, Meyher, France), 2.510X PCR buffer, 2.5 mM 
MgCl2, and 2 U of Taq DNA polymerase (Denmark). Then, 3 
min in 95 °C, 35 cycles including, denaturation for 45s at 94 
°C, primer annealing for 90s at 58 °C, and extension for 90s at 
72 °C and, finally, 7 min incubation at 72 °C in a Corbett Re-
search DNA thermal cycler (Corbett, Australia) were applied. 
The reaction products were then analyzed by electrophoresis 
on 1.2% agarose gels with 1% ethidium bromide (Fermentas, 
Germany). DNA from the reference strain, E. coli reference 
VTEC E. coli O157:H7 (ATCC; 43895), and a reagent blank, 
which contained all components except the template 
DNA(NTC), were included as positive and negative controls, 
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RESULTS 
 Fig.  (1) shows the pattern and distribution of some 
pathogens caused UTI. E. coli with 47.2%isolate had the 
highest frequency followed with Klebsiella oxytoca with 
147 (18.3%) isolate. Staphylococcus epidermidis (14.2%), 
Pseudomonas aeruginosa (8.2%), Proteus mirabilis (6.4%) 
and Staphylococcus aureus (4.3%), respectively. Approxi-
mately 20.9% strains of E. coli which isolated from urine 
were  -hemolytic  E. coli, 87.67% were SMAC positive 
and 3% were -hemolytic and SMAC positive E. coli were 
ETEC.In diagram, as you see, we found only 2.3 % of E. 
coli isolated from urine children with UTI was Enterohem-
orrhagic. (Figs. 2 and 3). The result electrophoresis   
Products seen on gel electrophoresis after multiplex PCR. 
lane M: ladder, lane 1, 2, 3: vtx-1 lane 6, 7, 8: vtx-2 (Fig. 4). 
DISCUSSION 
  This study confirms E.coli O157:H7 as one of the ma-
jor causative agent of severe UTI in children. Studies have 
shown that VTEC strain is commonly isolated in hemolytic 
colitis and hemolytic uremic syndrome belonging to   
serogroup O157 [23,24,26]. Following this assertion, VTEC 
is vtx on the increase in UTI subjects with 16.7%, while 
chronic PID of 100% -1 suggest an absolute prevalence and 
also gynaecological condition given an inference of 100% vtx -
1 & 2. Then if, vtx -1 and vtx -1&2 could give such an increas-
ing prevalence, then many of these patients could as well   
be suffering from undiagnosed life threatening hemorrhagic 
colitis (HC) and hemolytic uremic syndrome [23]. Very scanty 
documentation of E.coli O157:H7 prevalence in UTI and other 
renal related diseases could not be obtained. Comparation of 
data was not possible from other part of the country due to 
poor documentation.  
 
 
Fig. (4). The prevalence of verotoxin genes in Verotoxigenic E.coli 
isolated from urine children with UTI. 
 
  In our study only 2.3 % of E.coli that isolated from chil-
dren's urine with UTI was Enterohemorrhagic. The prevalence 
of EHEC in Aslani and et al., studies (Institute Pasteur of Iran, 
Tehran 2008 in stool) and Nazek Al-Gallas (Tunisia,2007 in 
stool samples) was 44.5%, 11.1% respectively because EHEC 
is more dominant in stool than urine.  
  Since the detection of VT represents a rational, serotype 
independent strategy for the diagnosis of VTEC infections, 
simple and reliable procedures that allow the detection of VT. 
  For this purpose, we evaluated the performance of a 
VTEC-RPLA-SEIKEN assay(An reverse passive latex agglu-
tination Vero Toxigenic E. coli, for the detection and charac-
terization of VTx s in E. coli culture filtrates. In this study, 
44% of E.coli was non-verotoxigenic and 56% was verotoxi-
gene. Mohamed Karmali and et al., in 1998 Evaluated a Mi-
croplate Latex Agglutination Method (Verotox-F Assay) for 
Detecting and Characterizing of Verotoxins (Shiga Toxins) in 
Escherichia coli. They examined 68 VT-positive
 E. coli strains 
and 104 VT-negative strains E. coli and conclude that the 
Verotox-F assay is highly sensitive and specific for the detec-
tion and characterization of VTs in culture filtrates of human 
E. coli isolates. The test is rapid, reliable, and easy to perform; its 
results are easy to interpret; and it should allow testing for VT 
to become more widely performed. We also used a different 
method of latex agglutination but the same conclusion [27]. 
  In 1983–2002 in Atlanta, Georgia Brooks and et al., con-
sidered Non-O157 Shiga Toxin–Producing Escherichia coli 
 
Fig. (1). The prevalence and pattern of bacteria in urine children 
with UTI. 
 
Fig. (2). The prevalence of Enterohemorrhagic E.coli isolated from  
urine children with UTI. 
 
Fig. (3). The prevalence of Enterohemorrhagic E.coli isolated from 
urine children with UTI by VTEC _RPLA. 4    The Open Microbiology Journal, 2012, Volume 6  Navidinia et al. 
infections. They found 61% stx1, 22% stx2 and 17% both 
stx1 and stx2 while, we had 17/3 % vtx1, 52/45% vtx2 and 
30/3 both vtx1 and vtx2.This significant different percent is 
that in our study was on O157 Shiga Toxin–Producing 
Escherichia coli urinary tract Infections [28]. Thus we   
suggest rapid method for identification of this bacteria and 
proper treatment to inhibition of unwanted complications. 
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Table 1. Oligonucleotide Primers Sequences 
Amplification  
Product Size (bp) 
Reference Sequence  (5-3) Primer 
180 
Paton and Paton (1998) modified 
by Fitzmaurice J. (2003) 
ATAAATCGCCATTCGTTGACTACAGAACGCCCACTGAGATCATC 
VT1F 
VT1R 
255 
Paton and Paton (1998) modified 
by Fitzmaurice J (2003) 
GGCACTGTCTGAAACTGCTCCTCGCCAGTTATCTGACATTCTG 
VT2F 
VT2R 
Products seen on gel electrophoresis after multiplex PCR .lane M: ladder, lane 1, 2, 3: vtx-1 lane 6, 7, 8: vtx-2. 